AGADA Biosciences, a CRO specializing in rare neuromuscular disease drug development in Halifax, sought to enhance its regulatory compliance. As an early adopter, Senior Quality Assurance Manager Chris Rice used Qualio’s compliance management tool to identify compliance gaps efficiently. Qualio helped AGADA streamline regulatory testing and improve quality assurance processes, enabling the team to better meet sponsor and regulator standards. This support accelerated AGADA’s drug development programs by ensuring rigorous adherence to compliance requirements through a user-friendly, effective system.

Join for free to read